Evidence map›Paper›PMID 28968399›Full record

ArticlePLoS medicine2017

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and budget impact in priority setting for global health programs.

Alyssa Bilinski, Peter Neumann, Joshua Cohen, Teja Thorat, Katherine McDaniel, Joshua A Salomon

Registry-linked trialAbstract read
In one paragraph

Article in PLoS medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05002322 (Scaling Out and Scaling Up the Systems Analysis and Improvement Approach to Optimize the Hypertension Diagnosis and Care Cascade for HIV-infected Individuals), which is not on this map. Cited by 55 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05002322 nacompletednot on this mapstarted 2023, after this paper: background citation

Scaling Out and Scaling Up the Systems Analysis and Improvement Approach to Optimize the Hypertension Diagnosis and Care Cascade for HIV-infected Individuals

TypeinterventionalSponsorEduardo Mondlane UniversityRan2023 to 2025Enrolled18ConditionsHypertensionArmsSystems Analysis and Improvement Approach
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Obstetric pharmacoeconomics.Expert review of pharmacoeconomics & outcomes research · 2026
    Review
  12. Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alyssa BilinskiInterfaculty Initiative in Health Policy, Harvard University, Cambridge, Massachusetts, United States of America.ORCID http://orcid.org/0000-0001-9108-6660
Peter NeumannCenter for Evaluation and Risk in Health, Tufts Medical Center, Boston, Massachusetts, United States of America.ORCID http://orcid.org/0000-0003-1226-4073
Joshua CohenCenter for Evaluation and Risk in Health, Tufts Medical Center, Boston, Massachusetts, United States of America.ORCID http://orcid.org/0000-0003-1737-0991
Teja ThoratCenter for Evaluation and Risk in Health, Tufts Medical Center, Boston, Massachusetts, United States of America.
Katherine McDanielSchool of Social and Political Science, University of Edinburgh, Edinburgh, Scotland, United Kingdom.ORCID http://orcid.org/0000-0001-6052-8163
Joshua A SalomonCenter for Health Policy and the Center for Primary Care and Outcomes Research, Stanford University, Stanford, California, United States of America.

Funding

AHRQ HHS T32 HS000055
6 · The paper itself

Abstract

Potential cost-effective barriers in cost-effectiveness studies mean that budgetary impact analyses should also be included in post-2015 Sustainable Development Goal projects says Joshua Salomon and colleagues.

Indexed as

Cost-Benefit AnalysisBudgetsGlobal HealthHealth PolicyHumansUniversal Health Insurance

Identifiers

PMID28968399
PMCPMC5624570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.